Approximately 4 million people in the United States have hepatitis C. Many do not have any symptoms, so those who have risk factors for the disease should get tested. Symptoms, when they do appear, include itchiness, confusion, swelling of the belly and feet, and jaundice of the eyes and skin. Once these symptoms appear, serious damage may already have been done to the liver. The disease is curable, however, so if a patient tests positive, he or she can work with a doctor to map out a treatment plan.
The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.
The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.